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Introduction: Throughout history, therapeutically active plant products have received substantial attention due
to their valuable role in the discoveries of specific medications. The aim of this study was to assess, for the first
time, the antimicrobial, antioxidant, antilipase, anti-α-amylase and cytotoxic properties of four fractions derived
from Anchusa ovata Lehm. (AO) leaves.
Methods: Antioxidant, antilipase and anti-amylase potentials of (AO) were established using DPPH (1,1-diphenyl-
2-picrylhydrazyl), p-nitrophenyl butyrate and dinitro-salicylic acid procedures, respectively, while antimicrobial
activity was conducted using broth microdilution assay against eight Gram-positive, Gram-negative bacterial
strains in addition to one fungal strain. Moreover, the MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethox-
yphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] cytotoxic assay was utilized against cervical cancer cells (HeLa).
Results: The methanol fraction of AO showed potential antioxidant, antilipase, and α-amylase inhibitory ac-
tivities with IC50 values of 9.55 ± 0.13, 53.7 ± 0.41 and 16.55 ± 1.84 μg/ml, respectively compared with the
positive controls Trolox, Orlistat and Acarbose that had IC50 values of 3.23 ± 0.92, 12.3 ± 0.35 and
28.18 ± 1.22 μg/ml, respectively. Moreover, the hexane, acetone, and methanol fractions had wide ranges of
antimicrobial potential. In addition, the cytotoxic activity outcomes which showed the best activity was for the
aqueous followed by acetone, hexane and methanol fractions with IC50 values of 1.04, 2.72, 3.96 and 17.67mg/
ml, respectively.
Conclusion: Our data demonstrate a wide range of biological characteristics for each AO plant fraction. This
profiling information about the methanol fraction provided important data for further research and pharma-
ceutical applications.
1. Introduction
In the human body, free radicals created by various biochemical
processes such as the reduction of molecular oxygen in the aerobic
respiration creating hydroxyl and superoxide radicals can be externally
formed by splitting water molecules to produce the hydroxyl radicals
using the gamma rays of electromagnetic radiation [1,2]. In fact, many
studies demonstrated that the presence of uncontrolled free radicals in
human body is usually correlated with broad diversity of illnesses such
as asthma, atherosclerosis, diabetes, cancer, Alzheimer's disease, senile
dementia, Parkinson’s disease and obesity [3,4]. In 2016, approxi-
mately two billion adults were classified as overweight and more than
600 million of them were classified as obese [5].
In fact, obesity and being overweight are the major risk factors for
many diseases especially cardiovascular diseases which are the leading
cause of death around the world, while obesity is considered as one of
the major risk factors for insulin resistance and diabetes [6,7].
Diabetes mellitus is considered one of the most dangerous metabolic
disorders and a major cause of mortality and morbidity in the world due
to its complications in the micro- and macro- vascular systems [8]. The
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number of diabetic people has increased from about 100 million in
1980 to more than 400 million in 2014 [9].
Non-communicable diseases are considered the main leading cause
of death worldwide, and cancer occupies the top places in this list.
According to the American Institute for Cancer Research, 2018 esti-
mations showed that there are more than 18 million cancer cases
around the world [10]. World Health Organization has announced that
cancer incidence rate will double in the next two decades unless action
is taken [11].
Cancer is a major problem for human life and a public health
challenge in the 21st century. The world must direct its resources to find
urgent medical treatment and provide strategies for this disease
[12,13]. In fact, most of the chemotherapeutic drugs used for the
treatment of cancer are extracted from plants such as vinblastine from
the Vinca plant and taxol from the Pacific yew bark [14,15].
During the last decade, antimicrobial resistance has started to pose
a catastrophic threat to the availability of effective treatments and
prevention strategies for a huge range of infectious diseases caused by
bacteria, fungi, parasites, and viruses. It is a serious threat to global
health systems that requires action across all societies, governmental
and non-governmental health sectors, and without sufficient and ef-
fective antimicrobial drugs, the success of cancer chemotherapy and
surgical operations will be compromised. Global estimations docu-
mented in 2016 suggested that about half billion patients developed
multi-drug resistance of Tuberculosis only, and antimicrobial re-
sistance is complicating the fight against malaria and HIV, as well
[16].
Plants have been used as therapeutic agents for the cure of different
illnesses and as cosmeceutical products since the prehistoric times [17].
Up to date, phytotherapeutic products are still the mainstay for primary
health care of about 80 % of the populations in the developing countries
because they have fewer adverse effects, are more compatibility with
the human body and have better cultural acceptability [18,19]. More-
over, the last two decades have shown a considerable increase in their
usage even in the developed countries. For example, in the United
States, botanical medicines and nutraceutical supplements sold cur-
rently in health food markets generated about 8 billion dollars of sales
in 2017 compared to 4 billion dollars in 1996 [20].
Anchusa genus is represented by fifty species which are distributed
in the Irano-Turanian and Mediterranean areas. These plants are uti-
lized widely in the Arabian and Islamic medicine as potent antibacterial
agents and used for the treatment of different bacterial infections of the
respiratory, gastrointestinal and urinary systems [21–23].
Anchusa ovata Lehm. is a synonym of Anchusa arvensis subsp. or-
ientalis (L.) Nordh. and Lycopsis arvensis L. It belongs to the
Boraginaceae family which is commonly named as annual bugloss and
small bugloss. It is an annual herbaceous hairy plant, which reaches
50 cm in height and has blue, small, and tubular flowers, with one seed
per fruit, while the leaves are very hairy and rough. However, it is
widely grown on the sandy heaths, arable lands, bares and waste places
throughout the southern regions of Europe and some Mediterranean
basin countries [24].
The plant roots contain naphthoquinone pigments of the en-
antiomeric alkannins and shikonins group, which have antimicrobial,
anti-inflammatory and wound-healing potentials. Other investigations
have distinguished that these molecules have potential anticancer ac-
tivity [25]. In addition, the volatile oil of (AO) plant has a moderate
anticholinesterase activity [26]. Moreover, the treatment with 100mg/
ml hydroalcoholic extract of (AO) reduced the rate of hemoglobin
glycation to 41.90 ± 1.2 % [27].
To the best of the authors’ knowledge, no previous studies have
been carried out to determine the antimicrobial, cytotoxic, antioxidant,
antilipase and antiamylase activities of AO plant leaves. This in-
vestigation aimed to evaluate the antibacterial, antifungal, antioxidant
antiobesity, antidiabetic and cytotoxic effects of (AO) aqueous, acetone,
hexane, and methanol fractions.
2. Material and methods
2.1. Preparation of plant material
The leaves of AO were collected from the West Bank area of
Palestine. Botanical characterization was carried out by a pharmacog-
nosist Dr. Nidal Jaradat at the Pharmacognosy Laboratory at An-Najah
National University and stored under voucher specimen number
(Pharm-PCT-161).
The separated leaves of AO plants were washed several times with
deionized water then dehydrated in the shade for twenty days at con-
trolled humidity (55 ± 5 RH) and temperature (25 ± 2 °C). After their
dehydration, the plant materials were pulverized using an electric mill
into a fine powder and kept in a paper bag with proper labeling for
further use.
2.2. Exhaustive fractionations method
The ground leaves were exhaustively extracted utilizing four solvent
exhaustive fractionations assay which was carried out by using different
solvents with various degrees of polarities including methanol, water,
acetone, and hexane. Briefly, 30 g of the dried plant leaves were taken
and placed in a glass bottle then extracted separately with 300ml of
each solvent. Each bottle of plant leaves and the solvent was placed on a
shaking machine for 72 h at ambient temperature and was set at
400 rpm. Each solvent was filtered utilizing the suction filtration assay.
Then each exhaustive extract was dried in a different way; organic ones
were kept in the incubator device at 25 °C until each solvent completely
evaporated, while water fraction was dried by using a freeze-dryer for
48 h. Each obtained dried fraction was stored in the refrigerator at a
temperature of 2–8 for later use. The obtained percentages yields were
0.71, 1.38, 1.1, and 3.5 %, for the aqueous, methanol, hexane and
acetone fractions, respectively.
2.3. Phytochemical analysis
The phytochemical screening tests were established according to the
standard analytical methods to identify the presence of primary and
secondary metabolic groups including carbohydrates, starch, flavo-
noids, saponins, glycosides, alkaloid, tannins and phenols, protein and
terpenoids [28].
2.4. DPPH radical scavenging activity
The working plant solutions (1mg/ml) were prepared by mixing
0.1 g of each plant fraction in 0.1 l of methanol then these solutions
were diluted by methanol to obtain different concentrations (2, 5, 10,
20, 50 and 100 μg/ml). One ml from each plant fraction working so-
lution and 1ml of methanol were prepared with 1ml of DPPH solution
and incubated for 30min in dark place at room temperature. The blank
solution was prepared by replacing the plant fraction solution with
methanol. Trolox was used as a reference and the absorbance was
measured by UV–vis spectrophotometer at 517 nm and compared with
the control. The antioxidant activity was calculated by the following
equation.
I (%)= [ABSblank– ABStest]/[ABSblank]) *100 %
Where, I (%), is the percentage of antioxidant activity [29]. However,
Trolox which is a vitamin E analog and has powerful antioxidant po-
tential was used as a positive control in the current experiment.
2.5. Porcine pancreatic lipase enzyme inhibitory method
One mg/ml stock plant dilution was made by dissolving 0.1 g from
each plant fraction in 100ml of Dimethyl sulfoxide (DMSO). The
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produced solution was diluted several times to obtain different con-
centrations (50, 100, 200, 300 and 400 μg/ml). In addition, a lipase
enzyme stock solution (1mg/ml) was directly prepared before use by
dissolving 25mg of lipase enzyme powder in 25ml of 10 % DMSO. The
p-nitrophenyl butyrate (PNPB) stock solution was prepared by dissol-
ving 20.9mg PNPB in 2ml of acetonitrile. 0.2 ml from each plant
fractions was prepared. Serial dilutions were mixed with 0.1 ml of li-
pase enzyme stock solution and completed with Tris−HCl solution to
reach 1ml of volume. Then incubated for 15min at 37 °C in water bath
and after 15min, 100 μl of PNPB solution were added and incubated for
30min at 37 °C. The blank solution was prepared by mixing 100 μl of
lipase enzyme (1mg/ml) solution with Tris−HCl solution up to 1ml.
Orlistat which is a potent antilipase drug was used as a positive control
and followed the same previous steps as plant fraction. The absorbance
was measured utilizing a spectrophotometer (UV–vis) at 405 nm.
However, the lipase enzyme inhibitory potential was measured utilizing
the following equation:
I (%)= [ABSblank – ABStest]/[ABSblank]) *100 %
Where, I (%), is the percentage inhibition of lipase enzyme [30].
2.6. α-Amylase inhibitory method
A plant working solution (1mg/ml) was prepared by mixing 25mg
of each plant fraction in 10 % of DMSO. This solution was then diluted
by the buffer to obtain different dilutions (10, 50, 70, 100, 500 μg/ml).
Subsequently, an α-amylases enzyme stock solution (2 units/ml) was
prepared by dissolving 12.5mg of α-amylase enzyme in a minimum
amount of 10 % DMSO and the buffer solution were added up to
100ml. Then corn starch solution was prepared by dissolving 1 g of
starch in 100ml distilled water. A 200 μl from each plant fraction stock
solution was mixed with 200 μl of α-amylase stock solution and in-
cubated for 10min at 30 °C in a water bath. After that, 200 μl of corn
starch solution were added and incubated for 3min at 30 °C. Moreover,
3,5-dinitro salicylic acid was added and boiled in a water bath at
85–90 °C for 10min and after the solution was cooled, 5ml of distilled
water was added and prepared blank solutions throughout the re-
placement of the (AO) fractions with 200 μl of buffer solution. In ad-
dition, the commercial antidiabetic drug Acarbose was utilized as a
positive control. The optical activity of the prepared solutions was as-
sessed at 540 nm utilizing a UV–vis spectrophotometer. The α-amylase
inhibitory potential was calculated utilizing the following equation:
I (%)= [ABSblank – ABStest]/[ABSblank]) *100 %
Where I (%), is the α-amylase inhibitory percentage [31].
2.7. Antimicrobial method
Broth micro-dilution method was used to determine the antimicrobial
activity of four solvents fractions of (AO). However, the screened strains
including Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae,
Proteus vulgaris, Enterococcus faecium, Pseudomonas aeruginosa, and
Candida albicans were American Type Culture Collection types and have
ATCC codes 25922, 13883, 25923, 8427, 700221, 9027, and 90028,
respectively in addition to a clinical strain of Methicillin-resistant
Staphylococcus aureus (MRSA). Each fraction of AO plant was dissolved in
DMSO in a concentration of 50mg/ml for methanol, acetone and water
fractions and 25mg/ml for hexane fraction. Then, two-fold serial dilu-
tions of the antimicrobial agent were prepared in liquid growth medium
(Mueller Hinton for the bacteria and RPMI 1640 for the Candida albicans)
dispensed in 96-well micro-titration plate. After that, each well was in-
oculated with microbial inoculums, which were prepared in the same
medium after dilution of standardized microbial suspension adjusted to
0.5 McFarland scale. Controls were performed on the same plate, in-
cluding two negative controls that involved; media alone and media with
plant extract serially diluted, and one positive control that contains mi-
crobe in addition to the media. After well mixing, the 96-well micro-
titration plates were incubated at 37 °C for 18−24 hrs for bacteria and
35 °C for 24−48 hrs for Candida albicans [32–34].
2.8. Cytotoxicity procedure
RPMI-1640 medium was utilized to culture the cervical adeno-
carcinoma (HeLa) cancer cells containing 10 % of fetal bovine serum,
1% penicillin/streptomycin and 1% L-glutamine. The HeLa cells were
grown in a humidified environment at 37 °C degree with 5% CO2 at-
mosphere, then was used a 96-well plate to seed the cells at 2.6 *10^4
cell/well. After 24 h, cells were treated with various concentrations of
the tested (AO) fractions. Cell viability was assessed by the Cell-Tilter
96® Aqueous One Solution Cell Proliferation (MTS) assay according to
the manufacturer’s instructions (Promega Corporation, USA). Briefly, at
the end of the treatment, 20 μl of MTS solution per 100 μl of media were
added to each well and incubated at 37 °C for 2 h. Absorbance was
measured using UV–vis-spectrophotometer at wavelength of 490 nm.
2.9. Statistical analysis
All the conducted experiments were determined in triplicate. The
results are presented as means ± standard deviation (SD). Statistical
analysis was performed using GraphPad Prism software version 6.01.
Comparisons between three or more groups were performed by one-way
analysis of variance (ANOVA), followed by the Bonferroni post hoc test.
3. Results
3.1. Preliminary phytochemical analytical tests
The standard analytical tests revealed the presence of various pri-
mary and secondary phytochemical metabolites in the hexane, acetone,
methanol and aqueous fractions including proteins, carbohydrates, al-
kaloids, saponins, glycosides, steroids, terpenoids, tannins and phenols
as shown in Table 1.
3.2. Antioxidant activity
As depicted in Table 2 and Fig. 1, the free radical scavenging
characters’ outcomes revealed that the methanol fraction has the most
potent antiradical activity followed by the acetone fraction with IC50
values of 9.55 ± 0.13 and 13.18 ± 0.13 μg/ml, respectively.
3.3. Antilipase activity
As illustrated in Table 3 and Fig.2, extracts derived from AO in-
hibited the activity of pancreatic lipase enzyme in a dose-dependent
manner. IC50 values of hexane, acetone, methanol, and aqueous frac-
tions and Orlistat (commercial antiobesity drug) were 501.18 ± 0.65,
Table 1
Standard phytochemical analysis of Anchusa ovata (AO) four solvents fractions.
Phytochemical test Hexane Acetone Methanol Aqueous
Proteins + + + –
Sugars – + + +
Carbohydrates – + + +
Phenols and tannins – + + +
Flavonoids – – – –
Alkaloids – + – +
Saponins + – – –
Glycosides + + + +
Killer killani – + + +
Steroids – + + +
Terpenoids – – + –
N. Jaradat, et al. European Journal of Integrative Medicine 34 (2020) 101066
3
331.1 ± 0.47, 53.7 ± 0.41, 75.85 ± 0.62 and 12.3 ± 0.35 μg/ml,
respectively.
3.4. α-Amylase inhibitory activity
As demonstrated in Table 4 and Fig. 3, hexane, acetone, methanol
and aqueous fractions obtained from (AO) possessed in vitro inhibitory
activity against porcine pancreatic α-amylase activity in a concentra-
tion-dependent manner with IC50 values 63 ± 1.89, 83.17 ± 0.44,
16.55 ± 1.84 and 72.44 ± 1.86 μg/ml, respectively. While the IC50 of
the commercial antidiabetic drug was 28.18 ± 1.22 μg/ml.
3.5. Antimicrobial effects
Broth micro-dilution method was used to determine the suscept-
ibility of microorganisms to antimicrobial drugs, which is the most
popular assay in the United States. The outcomes of the current study
revealed that the AO plant hexane, acetone, and methanol fractions
have various degrees of antimicrobial effects against S. aureus,MRSA, P.
vulgaris, P. aeruginosa, K. pneumoniae, E. coli, and E. faecium, while the
aqueous fraction did not show any antimicrobial effect against the se-
lected microbial strains as shown in Table 5. However, the AO plant
aqueous, hexane, acetone, and methanol fractions did not reveal any
antifungal effects against C. albicans.
3.6. Cytotoxic activity
As shown in Table 6, extracts derived from AO inhibited the growth
of cells in a dose-dependent manner. The IC50 values of methanol,
hexane, acetone, and aqueous fractions were 17.67, 2.72, 3.96 and
1.04mg/ml, respectively.
4. Discussion
No one can deny the great value of the aromatic and medicinal
plants in the drug discovery and developments in addition to their
important role in the pharmaceutical, cosmeceutical and food in-
dustries [35].
4.1. Antioxidant activity
The leaves of the Anchusa ovata Lehm. plant contain cyanidin 3-
glucoside and delphinidin 3-glucoside polyphenolic anthocyanin mo-
lecules, which have potential antioxidant activity and can protect tis-
sues and cells from the damages caused by the oxidative stress and
decrease the risk of cardiovascular various diseases and cancer as well
as reduce the compilations of diabetes and other metabolic disorders
[36]. In a study conducted by Gharib et al. showed that the aqueous and
ethanol extracts of AO have an antioxidant effect with an IC50 value of
Table 2
Free radicals’ inhibitory activity IC50 values of four Anchusa ovata (AO) fractions and Trolox.
Conc. Trolox Hexane fraction Acetone fraction Methanol fraction Aqueous fraction
0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0
2 53.43 ± 3.46 37.69 ± 0.19 38.64 ± 0 20.83 ± 0 13.445 ± 0.185
5 61.51 ± 0.34 34.66 ± 0.095 38.83 ± 0.19 20.83 ± 0 4.735 ± 0.185
10 91.41 ± 0.34 37.31 ± 0.095 44.89 ± 0 50.57 ± 0.19 9.85 ± 0
20 97.29 ± 0.34 37.12 ± 0 44.89 ± 0.19 85.42 ± 0.38 4.735 ± 0.185
50 96.8 ± 0.34 32.005 ± 0.185 63.07 ± 0.19 87.5 ± 0 0.57 ± 0.19
100 97.54 ± 0.69 27.46 ± 0.19 89.21 ± 0.185 91.1 ± 0.19 7.765 ± 0.185
IC50 (μg/ml),± SD 3.23 ± 0.92 Inactive 13.18 ± 0.13 9.55 ± 0.13 Inactive
Fig. 1. Free radical inhibitory activity of Anchusa ovata (AO) four fractions and
Trolox.
Table 3
Lipase inhibitory activity IC50 values of four Anchusa ovata (AO) fractions and Orlistat.
Conc. Orlistat Hexane fraction Acetone fraction Methanol fraction Aqueous fraction
0 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00
50 91.05 ± 0.77 19.59 ± 0.48 29.05 ± 0.48 53.37 ± 0.46 53.54 ± 0.71
100 93.1 ± 0.42 19.59 ± 0.48 38.34 ± 0.72 57.7 ± 0.47 57.7 ± 0.47
200 94.3 ± 0.42 31.58 ± 0.71 38.34 ± 0.72 57.7 ± 0.47 58.1 ± 0.95
300 97.4 ± 0.12 60.25 ± 0.78 55.5 ± 0.21 57.7 ± 0.47 58.1 ± 0.95
400 97.5 ± 0.00 60.25 ± 0.78 55.5 ± 0.21 94.37 ± 0.17 66.8 ± 0
IC50 (μg/ml),± SD 12.3 ± 0.35 501.18 ± 0.65 331.1 ± 0.47 53.7 ± 0.41 75.85 ± 0.62
Fig. 2. Porcine pancreatic lipase inhibitory activity of Anchusa ovata (AO) four
fractions and Orlistat.
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16.44 ± 2.80 and 14.12 ± 2.60 μg/ml, respectively [37]. However,
the current study revealed that the methanol fraction has the most
potent antioxidant action followed by the acetone fraction with IC50
values of 9.55 ± 0.13 and 13.18 ± 0.13 μg/ml, respectively com-
paring with Trolox, which has an IC50 value of 3.23 ± 0.92 μg/ml. On
the other hand, hexane and aqueous fractions were inactive.
4.2. Porcine pancreatic lipase inhibitory activity
In an investigation established by Conforti et al., they found that the
hydroalcoholic extract of Anchusa azurea flowers has antilipase effect
with an IC50 value more than 10,000 μg/ml [38]. While the current
investigation results showed that the methanol fraction of (AO) plant
has potential antilipase activity followed by an aqueous fraction with
IC50 doses of 53.7 ± 0.41 and 75.85 ± 0.62 μg/ml, respectively in
comparison with the commercial antilipase drug Orlistat which has a
lipase inhibitory activity with an IC50 value of 12.3 ± 0.35 μg/ml.
4.3. α-Amylase inhibitory activity
α-Amylase and α-glucosidase are the metabolic enzymes which are
charged in the hydrolysis of carbohydrates in the gastrointestinal tract,
also they are responsible for the metabolic disorder that causes post-
prandial hyperglycemia [39]. However, α-amylase hydrolyzes the
starch (amylum) and glycogen by the cleavage of α-1,4-glycosidic
bonds between the polysaccharide units of polysaccharides while the α-
glucosidase hydrolyzes the disaccharide to monosaccharide units,
which is the main cause of the postprandial hyperglycemia. Therefore,
the inhibitors of α-glucosidase and α-amylase enzymes are considered
among other effective agents that can regulate postprandial hypergly-
cemia and control type II of diabetes. It has been well acknowledged
that phytochemicals and plants extracts are potential alternatives to
chemical inhibitors against α-amylase and α-glucosidase [40].
In a study conducted by Sarikurkcu1 et al. found that the methanol
extract of Anchusa undulata from Turkey has an α-amylase inhibitory
activity with an IC50 value of 0.193 ± 0.006mmol ACEs/g extract [41].
However, the results of the current study showed that the methanol
fraction of AO plant had powerful α-amylase inhibitory activity even
stronger than the commercial α-amylase inhibitor Acarbose followed by
the aqueous and acetone fractions. The methanol fraction of our plant
has α-amylase inhibitory activity with IC50 dose of 16.55 ± 1.84 μg/ml,
which is much higher than the commercial antidiabetic drug (Acarbose)
which has an IC50 value of 28.18 ± 1.22 μg/ml.
4.4. Antimicrobial effects
Each year in the U.S.A., about 2 million patients are infected with
antibiotic-resistant bacterial pathogens, and about 23,000 people die as
a result. In this case, the world health care systems urgently need to
adjust the ways of using and prescribing antibiotics. Even more novel
antibiotics are discovered, without behavior changes, the resistance
against antibiotic will remain the major life-threat issue and these
changes also must include more work to decrease the spread of these
infections throughout the development of vaccines, body and food
hygiene [42].
The results revealed that the hexane, methanol, acetone fractions
have antibacterial activity against S. aureus with MIC values of 6.25,
6.25, 12.5mg/ml, respectively, while the methanol fraction was the
Table 4
α-Amylase inhibitory activity IC50 values of Anchusa ovata (AO)four fractions and Acarbose.
Conc. Acarbose Hexane fraction Acetone fraction Methanol fraction Aqueous fraction
0 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00
10 53.22 ± 1.2 10.8 ± 3.07 42.32 ± 0.13 67.3 ± 9.2 26.41 ± 0.78
50 54.91 ± 0.58 21.7 ± 0 43.61 ± 1.4 67.3 ± 0 35.13 ± 3.8
70 66.1 ± 1.34 28.2 ± 0 51.48 ± 0.27 67.3 ± 0 44.43 ± 4.4
100 66.1 ± 1.62 39.1 ± 6.1 53.43 ± 0.13 67.3 ± 0 70.15 ± 0.16
500 72.54 ± 1.37 52.17 ± 0.3 59.26 ± 0.26 86.9 ± 0 70.15 ± 0.16
IC50 (μg/ml),± SD 28.18 ± 1.22 63 ± 1.89 83.17 ± 0.44 16.55 ± 1.84 72.44 ± 1.86
Fig. 3. α-Amylase inhibitory activity of Anchusa ovata (AO) four fractions and
Acarbose.
Table 5
Antibacterial activity MIC values (mg/ml) of Anchusa ovata (AO) four fractions.
Fractions MRSA E. faecium E. coli k. pneumoniae P. aeruginosa P. vulgaris S. aureus
Hexane R R R R 6.25 R 6.25
Methanol R R R R 12.5 12.5 6.25
Acetone 12.5 12.5 12.5 12.5 12.5 R 12.5
Aqueous No antibacterial activity
R=Resistant.
Table 6
The cytotoxic activity of four Anchusa ovata (AO) solvent fractions.
Conc. Methanol
fraction
Acetone
fraction
Hexane
fraction
Aqueous
fraction
Relative quantity to control
0.3125 0.989882 1.155529 0.818118 0.981176
0.625 0.922588 1.065412 0.762824 0.923529
1.25 0.930353 1.061412 0.872235 0.386824
2.5 0.931765 0.834353 0.964941 0.143529
5 0.796706 0.118824 0.107529 0.150588
10 0.66147 0.133176 0.106118 0.187059
IC50 (mg/ml) 17.67 2.72 3.96 1.04
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only one which affected the growth of P. vulgaris with MIC dose of
12.5 mg/ml. Moreover, the hexane, methanol, acetone fractions in-
hibited the growth of P. aeruginosa with MIC doses of 6.25, 12.5,
12.5 mg/ml, respectively, while the acetone fraction was the least that
affected K. pneumoniae, E. coli, E. faecium and MRSA with MIC values of
12.5 mg/ml, respectively. Evidently, the hexane, methanol, acetone and
aqueous fractions of AO plant were inactive against the screened C.
albicans strain and the aqueous fraction was an inert fraction against all
of the screened pathogens.
A study conducted by Shtayeh et al. from Palestine found that the
aqueous extract of Anchusa strigosa has inhibition zone diameter against
S. aureus, E. coli, P. aeruginosa, K. pneumoniae, and C. albicans of 6.0mm,
respectively, while the ethanol extract has an inhibition zone diameter
of 14.7, 6.0, 6.0, 12.6, 6.0, and 10.6mm, respectively [43]. Another
study conducted by Miri et al. from Iran found that the ethanol leaf
extract of A. ovata has inhibition zone diameter against K. pneumoniae,
B. subtilis, E. coli, S. aureus, and P. aeruginosa were 9, 4, 9, 11 and
16mm, respectively. While the inhibition zones of the aqueous extract
were 6, 2, 8, 8 and 19mm, respectively [44].
4.5. Cytotoxic activity
The cytotoxic results showed that AO methanol, hexane, acetone,
and aqueous fractions have a little to moderate cytotoxic effect. The
cytotoxic activity of AO in different solvent fractions showed that the
highest activity was for aqueous followed by acetone, hexane and me-
thanol fractions with IC50 values of 1, 3, 4 and 17mg/ml, respectively.
This is less strong than previous reports by Boskovic et al., where
chloroform, ethyl acetate, ethanol, acetone, and petroleum extracts
derived from A. officinalis plant have shown to possess cytotoxic activity
against Hep 2 cancer cells with IC50 0.14 ± 2.12, 0.17 ± 0.2,
0.14 ± 0.87, 0.14 ± 1.30 and 0.18 ± 2.26mg/ml, respectively [45].
Our data suggest that fractions derived from AO, especially methanol,
have little cytotoxic effect and it could be considered safe, however, this
needs further in vivo validation.
This is the first report of antioxidant, antibacterial, antiamylase
antilipase and cytotoxic effects of AO plant four solvents fractions from
Palestine. The authors suggest that AO plant screened in this study
could be utilized to investigate pharmacologically active natural agents
that may lead to the discovery of new pharmaceutical entity.
However, further isolation and purification of potentially active
compounds and ultimately in-vivo screening are required to determine
the side effects, toxicological characteristics, pharmacokinetics and
pharmacodynamic effects of the AO plant active ingredients.
5. Conclusion
In comparison with the positive controls Trolox, Orlistat and
Acarbose, the methanol fraction of (AO) plant revealed potential anti-
oxidant, antilipase, and α-amylase inhibitory activities. Moreover, an-
timicrobial tests showed that the hexane, acetone, and methanol frac-
tions have a wide range of potential. In addition, the cytotoxic analysis
of the tested fractions revealed little to moderate cytotoxic activity,
suggesting a safe source of potential pharmacological compounds. It is
clearly shown that the methanol AO fraction should be tested further as
effective chemical against oxidative stress, hyperlipidemia, hypergly-
cemia, and safety to serve for replacement therapy of chemical drugs or
as natural supplement to help in decreasing the complications caused
by these lethal diseases.
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